SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is drawing significant attention as its circulating supply nears its maximum cap, fueling expectations of a potential 'supply shock' and treasury buybacks among bullish investors. This optimism is sharply contrasted by widespread community concerns regarding the Compound Foundation's financial health, governance challenges, and strong competition within the DeFi lending space.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Crypto is actively trending following the launch of its WolfSWAP, a cross-chain aggregator lauded by the community for its seamless functionality and potential for shared transaction fees. The Wolfpack is buzzing with bullish sentiment, foreseeing substantial growth driven by this utility and an even larger, innovative release anticipated in 2026, echoing early memecoin success stories.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following its recent FDA approval for Aqvesme, positioning it as the sole approved treatment for alpha- and beta-thalassemia. This significant regulatory milestone is sparking community discussion around its market potential and expected impact, driving considerable trading activity despite past investor concerns regarding other pipeline developments.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is seeing significant market momentum following FDA approval for YARTEMLEA, the first and only approved therapy for transplant-associated thrombotic microangiopathy (TA-TMA). The community is celebrating this long-awaited milestone, anticipating substantial price appreciation and buyout potential, bolstered by the company's existing multi-billion dollar deal with Novo Nordisk and a strengthened financial position. This development signals a new era for Omeros with considerable commercial opportunities and pipeline validation.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is a hot topic, fueled by its recent listing on Robinhood and strong ties to the Coinbase Base ecosystem. The community is buzzing with bullish sentiment, anticipating potential short squeezes and substantial upside as this RWA perp dex challenges market leaders like Aster and Hype. Discussions highlight upcoming buybacks and its role as a key project on Base.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RAVE CRYPTO is trending due to news surrounding Trumps World Liberty Financial's integration of Aster Trade into its USD1 expansion, which reportedly contributed to the RAVE token reaching a record high. The community is actively discussing the token's recent rally, with many highlighting its status as a relatively new coin with significant upside potential and limited legacy holders.

AIRO Group Holdings, Inc. engages in the purpose of acquiring and integrating various companies engaged in the aerospace and defense industry. It operates through the following segments: Avionics and Electronics, Electric Air Mobility, Drones, and Training. The Avionics and Electronics segment refers to its brand, Aspen Avionics, designs, certifies, and manufactures critical navigation, communication, and display components and integrated systems. The Electric Air Mobility segment transforms urban transportation with its development of an electric vertical take-off and landing (eVTOL) aircraft. The Drones perform crucial missions such as ISR and target tracking, mapping, surveying, inspection, and localization, enhancing military, and commercial operational efficiency worldwide. The Training segment relates to its brand, Coastal Defense, delivers specialized professional training services to the military and commercial aviation communities. The company was founded by Chirinjeev Kathuria on August, 30, 2021 and is headquartered in Albuquerque, NM.

AIRO Group Holdings Inc.

Airo Group Holdings Inc

AIRO Group Holdings is generating significant discussion after forming a joint venture to produce combat-proven UAV technology for defense markets and its recent inclusion in major market indexes. While some in the community view the stock as deeply undervalued amidst a surging drone sector, others voice skepticism stemming from past earnings surprises, insider actions, and recent dilution. The potential for substantial defense contracts, driven by evolving geopolitical demands and a shift towards domestic drone manufacturing, continues to drive active debate around its long-term prospects despite recent volatility.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently trending with high anticipation for its upcoming CES 2026 showcase and the continued impact of its AI-powered Athena platform, further bolstered by the recent Marigold acquisition. The community widely views the stock as significantly undervalued, expecting a major re-rating driven by consistent financial performance, increasing institutional ownership, and its strategic advantage in post-cookie marketing technology. Many believe a substantial breakout is imminent as the market fully recognizes its growth potential, despite recent price action.

Grayscale Investments LLC - Grayscale Zcash Trust (ZEC)

Grayscale Zcash Trust ZEC

Grayscale Zcash Trust (ZCSH) is capturing attention as its underlying asset, Zcash (ZEC), exhibits notable strength, sparking widespread community optimism for significant appreciation. Investors are actively discussing ZCSH as a strategic way to gain exposure to the privacy-focused cryptocurrency within traditional accounts. Many anticipate continued upside, citing Zcash's unique technology and potential future catalysts within the broader digital asset market.

Dogelon Mars

Dogelon Mars ($ELON) is trending amidst widespread community frustration, with many long-term holders lamenting significant losses and labeling it a "dead coin." Despite occasional references to forthcoming metaverse developments or a "Great Burn," widespread skepticism prevails as the token consistently underperforms during broader crypto market uptrends, leading to calls for delisting and general disillusionment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innoviva (NASDAQ:INVA) Share Price Crosses Above Two Hundred Day Moving Average - Here's Why

Innoviva (NASDAQ:INVA) Stock Crosses Above Two Hundred Day Moving Average - Here's Why...

Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are presently covering the company, Marketbeat Ratings...

FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea

(RTTNews) - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced that the U.S. Food and Drug Administration approved NUZOLVENCE (zoliflodacin) for oral suspension, a...

U.S. FDA Approves NUZOLVENCE (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral...

Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced the publication of positive results from a pivotal Phase 3 trial evaluating its investigational...

State Board of Administration of Florida Retirement System Cuts Stake in Innoviva, Inc. $INVA

State Board of Administration of Florida Retirement System decreased its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 80.4% in the second quarter, according to its most recent 13F filing...

Innoviva, Inc. $INVA Shares Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership raised its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 85.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...

Boston Partners Boosts Holdings in Innoviva, Inc. $INVA

Boston Partners lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 40.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 875,084...

Innoviva, Inc. $INVA Shares Purchased by American Century Companies Inc.

American Century Companies Inc. raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 23.3% in the 2nd quarter, according to the company in its most recent 13F filing with the...

Jefferies Financial Group Inc. Increases Stake in Innoviva, Inc. $INVA

Jefferies Financial Group Inc. raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 421.0% during the 2nd quarter, according to the company in its most recent Form 13F...

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.60	--	--	N/A
Q3 '25	$0.46	$1.08	134.78%	BEAT
Q2 '25	$0.50	$0.77	54.30%	BEAT
Q1 '25	$0.29	-$0.74	-351.87%	MISSED
Q4 '24	$0.37	$0.26	-29.73%	MISSED

INVA
Innoviva Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest INVA News

INVAInnoviva Inc